✦ LIBER ✦

Use of tadalafil in a patient with a secondary Raynaud's phenomenon not responding to sildenafil

✍ Scribed by Magnus Baumhaekel; Peter Scheffler; Michael Boehm

Book ID: 116760588
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 107 KB
Volume: 69
Category: Article
ISSN: 0026-2862
DOI: 10.1016/j.mvr.2005.03.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of oral iloprost in pat

Pharmacokinetics of oral iloprost in patients with Raynaud’s phenomenon secondary to systemic sclerosis

✍ M.C.H. Janssena; H. Wollersheim; Chr Kraus; M. Hildebrand; H.R. Watson; Th. Thie 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Comparable effects of sildenafil citrate

Comparable effects of sildenafil citrate and alprostadil on severe Raynaud's phenomenon in a patient with systemic sclerosis

✍ Y. Kamata; T. Kamimura; M. Iwamoto; S. Minota 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

O20 Efficacy of Tadalafil in secondary R

O20 Efficacy of Tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double blind randomized cross over trial

✍ P Shenoy; V Agarwal; S Kumar; K Sunil; LK Jha; U Singh; R Misra 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Cyanotic change of colon mucosa in a pat

Cyanotic change of colon mucosa in a patient with raynaud's phenomenon

✍ Masahiro Yamashita; Hiroyuki Funayama; Yoji Anami; Naoto Morikawa; Shigeko Inoku 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Studies of endogenous catecholamines in

Studies of endogenous catecholamines in patients with Raynaud's phenomenon secondary to progressive systemic sclerosis (scleroderma)

✍ Joseph D. Sapira; Gerald P. Rodnan; Eileen T. Scheib; Thelma Klaniecki; Margaret 📂 Article 📅 1972 🏛 Elsevier Science 🌐 English ⚖ 919 KB

Oral iloprost treatment in patients with

Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study

✍ Fredrick M. Wigley; Joseph H. Korn; M. E. Csuka; Thomas A. Medsger Jr.; Naomi F. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

## Objective: To evaluate the efficacy and tolerability of an oral preparation of iloprost, a prostacyclin analog, in patients with raynaud's phenomenon (rp) secondary to systemic sclerosis (scleroderma). ## Methods: A multicenter, randomized, parallel-group, placebo-controlled double-blind study